Vaxart (VXRT) Competitors $0.34 -0.01 (-1.43%) Closing price 04/17/2025 04:00 PM EasternExtended Trading$0.35 +0.00 (+1.19%) As of 04/17/2025 06:17 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock VXRT vs. BNTC, AURA, CYRX, RNAC, TSVT, AQST, TSHA, ATXS, ATYR, and ATAIShould you be buying Vaxart stock or one of its competitors? The main competitors of Vaxart include Benitec Biopharma (BNTC), Aura Biosciences (AURA), Cryoport (CYRX), Cartesian Therapeutics (RNAC), 2seventy bio (TSVT), Aquestive Therapeutics (AQST), Taysha Gene Therapies (TSHA), Astria Therapeutics (ATXS), Atyr PHARMA (ATYR), and Atai Life Sciences (ATAI). These companies are all part of the "pharmaceutical products" industry. Vaxart vs. Benitec Biopharma Aura Biosciences Cryoport Cartesian Therapeutics 2seventy bio Aquestive Therapeutics Taysha Gene Therapies Astria Therapeutics Atyr PHARMA Atai Life Sciences Vaxart (NASDAQ:VXRT) and Benitec Biopharma (NASDAQ:BNTC) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, community ranking, risk, institutional ownership, profitability, earnings, media sentiment, dividends and valuation. Which has better earnings and valuation, VXRT or BNTC? Benitec Biopharma has lower revenue, but higher earnings than Vaxart. Benitec Biopharma is trading at a lower price-to-earnings ratio than Vaxart, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVaxart$28.70M2.73-$82.46M-$0.34-1.01Benitec Biopharma$80K4,030.64-$21.75M-$1.51-9.11 Do analysts recommend VXRT or BNTC? Vaxart presently has a consensus target price of $3.00, suggesting a potential upside of 772.35%. Benitec Biopharma has a consensus target price of $24.71, suggesting a potential upside of 79.74%. Given Vaxart's higher probable upside, analysts plainly believe Vaxart is more favorable than Benitec Biopharma.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Vaxart 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Benitec Biopharma 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 2 Strong Buy rating(s) 3.22 Which has more risk & volatility, VXRT or BNTC? Vaxart has a beta of 1.57, suggesting that its stock price is 57% more volatile than the S&P 500. Comparatively, Benitec Biopharma has a beta of 0.76, suggesting that its stock price is 24% less volatile than the S&P 500. Does the MarketBeat Community prefer VXRT or BNTC? Vaxart received 114 more outperform votes than Benitec Biopharma when rated by MarketBeat users. However, 65.67% of users gave Benitec Biopharma an outperform vote while only 65.61% of users gave Vaxart an outperform vote. CompanyUnderperformOutperformVaxartOutperform Votes31165.61% Underperform Votes16334.39% Benitec BiopharmaOutperform Votes19765.67% Underperform Votes10334.33% Do insiders and institutionals hold more shares of VXRT or BNTC? 18.0% of Vaxart shares are owned by institutional investors. Comparatively, 52.2% of Benitec Biopharma shares are owned by institutional investors. 2.6% of Vaxart shares are owned by company insiders. Comparatively, 1.3% of Benitec Biopharma shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Does the media favor VXRT or BNTC? In the previous week, Benitec Biopharma had 4 more articles in the media than Vaxart. MarketBeat recorded 5 mentions for Benitec Biopharma and 1 mentions for Vaxart. Benitec Biopharma's average media sentiment score of 0.56 beat Vaxart's score of 0.55 indicating that Benitec Biopharma is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Vaxart 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Benitec Biopharma 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is VXRT or BNTC more profitable? Benitec Biopharma has a net margin of 0.00% compared to Vaxart's net margin of -431.61%. Benitec Biopharma's return on equity of -44.61% beat Vaxart's return on equity.Company Net Margins Return on Equity Return on Assets Vaxart-431.61% -110.46% -62.78% Benitec Biopharma N/A -44.61%-41.25% SummaryBenitec Biopharma beats Vaxart on 12 of the 19 factors compared between the two stocks. Get Vaxart News Delivered to You Automatically Sign up to receive the latest news and ratings for VXRT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VXRT vs. The Competition Export to ExcelMetricVaxartBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$78.48M$2.84B$5.29B$7.35BDividend YieldN/A1.87%5.12%4.31%P/E Ratio-0.8430.4821.7117.77Price / Sales2.73441.91379.3997.65Price / CashN/A168.6838.2234.64Price / Book0.913.466.443.98Net Income-$82.46M-$72.06M$3.21B$247.44M7 Day Performance-3.45%2.52%2.81%1.82%1 Month Performance-39.67%-15.73%-8.67%-6.98%1 Year Performance-59.17%-26.11%11.32%1.49% Vaxart Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VXRTVaxart1.701 of 5 stars$0.34-1.4%$3.00+772.3%-60.3%$78.48M$28.70M-0.84120BNTCBenitec Biopharma2.2109 of 5 stars$12.02-2.4%$24.43+103.2%+186.5%$281.88M$80,000.00-7.9620Short Interest ↑AURAAura Biosciences1.8205 of 5 stars$5.52+1.7%$22.75+312.1%-23.8%$277.24MN/A-3.1950Short Interest ↑CYRXCryoport2.5064 of 5 stars$5.49+2.6%$11.83+115.5%-66.9%$274.01M$228.39M-1.621,020Analyst ForecastRNACCartesian Therapeutics1.7207 of 5 stars$10.11+1.1%$42.14+316.8%-43.2%$261.92M$38.91M-0.1964TSVT2seventy bio1.9348 of 5 stars$4.95flat$6.67+34.7%-1.6%$259.07M$37.86M-2.66440Short Interest ↓Positive NewsHigh Trading VolumeAQSTAquestive Therapeutics1.8191 of 5 stars$2.62-3.3%$10.57+303.5%-36.0%$259.04M$57.56M-5.82160Gap DownTSHATaysha Gene Therapies2.6728 of 5 stars$1.24+1.6%$6.63+434.3%-49.4%$254.20M$8.33M1.97180ATXSAstria Therapeutics2.4671 of 5 stars$4.50-3.4%$26.60+491.1%-61.7%$253.95MN/A-2.1530Gap DownHigh Trading VolumeATYRAtyr PHARMA2.5929 of 5 stars$2.85+8.8%$18.60+552.6%N/A$253.25M$235,000.00-3.0353Positive NewsATAIAtai Life Sciences1.8705 of 5 stars$1.27-3.1%$10.50+726.8%-25.8%$251.85M$308,000.00-1.5780 Related Companies and Tools Related Companies Benitec Biopharma Competitors Aura Biosciences Competitors Cryoport Competitors Cartesian Therapeutics Competitors 2seventy bio Competitors Aquestive Therapeutics Competitors Taysha Gene Therapies Competitors Astria Therapeutics Competitors Atyr PHARMA Competitors Atai Life Sciences Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:VXRT) was last updated on 4/18/2025 by MarketBeat.com Staff From Our PartnersElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredThey Won’t Tell You This About GoldInflation, digital currency, and government policy are quietly eating away at your savings — and most people w...American Alternative | Sponsored🥾⛏️👷♂️ What I Learned From Numerous Mine Visits...Twenty years ago, I made a decision that changed my life. Instead of sitting behind a desk analyzing mining...Golden Portfolio | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredThe Crypto Market is About to Change LivesI've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vaxart, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vaxart With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy VXRT Stock Free VXRT Stock Alerts